RFS
RARE icon

Rockefeller Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History

Rockefeller Financial Services’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$121K Sell
2,599
-398,027
-99% -$19.5M ﹤0.01% 371
2017
Q3 		$21.3M Sell
400,626
-7,753
-2% -$459K 0.41% 61
2017
Q2 		$25.4M Buy
408,379
+33,716
+9% +$2.03M 0.5% 55
2017
Q1 		$25.4M Sell
374,663
-5,098
-1% -$389K 0.51% 50
2016
Q4 		$26.7M Buy
379,761
+7,210
+2% +$512K 0.54% 46
2016
Q3 		$26.4M Sell
372,551
-23,795
-6% -$1.52M 0.55% 47
2016
Q2 		$19.4M Sell
396,346
-6,962
-2% -$450K 0.39% 52
2016
Q1 		$25.5M Buy
403,308
+113,401
+39% +$7.42M 0.5% 48
2015
Q4 		$32.5M Buy
289,907
+83,741
+41% +$8.37M 0.63% 47
2015
Q3 		$19.9M Buy
206,166
+195,335
+1,803% +$22.4M 0.4% 56
2015
Q2 		$1.11M Hold
10,831
– – 0.02% 186
2015
Q1 		$672K Sell
10,831
-498
-4% -$27.7K 0.01% 220
2014
Q4 		$497K Sell
11,329
-1,040
-8% -$47.7K 0.01% 240
2014
Q3 		$700K Sell
12,369
-13,682
-53% -$688K 0.02% 230
2014
Q2 		$1.17M Buy
26,051
+14,380
+123% +$592K 0.03% 211
2014
Q1 		$571K Buy
+11,671
New +$601K 0.01% 247

Other funds holding RARE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Rockefeller Financial Services's RARE Position: Q4 2017 in Review

Rockefeller Financial Services reduced its Ultragenyx Pharmaceutical (RARE) stake by 99% in Q4 2017, selling an estimated $19.5M and leaving 2,599 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

Rockefeller Financial Services first reported a position in RARE in Q1 2014 and has held it in 16 quarters since. The position peaked at $32.5M in Q4 2015. 163 funds tracked by Wall St. Rank hold RARE as of Q4 2017.

  • Rockefeller Financial Services held 2,599 shares of Ultragenyx Pharmaceutical worth $121K as of Q4 2017.
  • Rockefeller Financial Services sold 398,027 Ultragenyx Pharmaceutical shares in Q4 2017, an estimated $19.5M.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #371 holding.
  • Rockefeller Financial Services first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 16 quarters since.
  • Rockefeller Financial Services's Ultragenyx Pharmaceutical position peaked at $32.5M in Q4 2015.
  • 163 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.